Fennec Pharmaceuticals Inc. FENC
Set alert
10.24 USD -0.71 -6.48%
At close · Oct 30
10.24 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
10.14 Day range 10.99
5.77 52-week range 12.78
- YTD
- +32.99%
- 1 year
- +22.93%
- Open
- 10.92
- Prev close
- 10.95
- Mkt cap
- 359.09M
- Vol
- 195.65K
- Avg vol
- 187.92K
- EPS
- -0.12
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.14
- High
- 10.99
- Forward P/E
- 16.78
- Beta
- 0.27
- Short ratio
- 13.06
- Inst. own
- 54.70%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.08
- 200-d avg
- 6.71
- 1y target
- 13.60
Financial health
Altman Z-Score
3.89 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -21.4×
FY 2016 5y median -18.7× FY 2025
P/S 4.9×
FY 2016 5y median 4.9× FY 2025
P/B 6.3×
FY 2016 5y median -25.7× FY 2025
P/FCF -17.6×
FY 2016 5y median -14.0× FY 2025
EV/EBITDA -24.6×
FY 2016 5y median -11.2× FY 2025
EV/Sales 4.1×
FY 2016 5y median 4.1× FY 2025
FCF Yield -5.7%
FY 2016 5y median -5.7% FY 2025
Profitability
Gross Margin 91.6%
FY 2016 5y median 93.3% FY 2025
Operating Margin -14.2%
FY 2016 5y median -14.2% FY 2025
Net Margin -21.8%
FY 2016 5y median -21.8% FY 2025
ROE -27.8%
FY 2016 5y median 7.4% FY 2025
ROIC -10.7%
FY 2016 5y median -67.5% FY 2025
ROA -13.9%
FY 2016 5y median -59.7% FY 2025
Growth (YoY)
Revenue -6.1%
FY 2016 FY 2025
Operating Income -356.0%
FY 2016 FY 2025
EPS (diluted) -2150.0%
FY 2016 FY 2025
Free Cash Flow -146.2%
FY 2016 FY 2025
Financial Health
Current Ratio 6.3×
FY 2016 5y median 6.3× FY 2025
Quick Ratio 6.2×
FY 2016 5y median 6.2× FY 2025
Debt / Equity 0.0×
FY 2016 5y median -2.7× FY 2025
Net Debt / EBITDA 4.9×
FY 2016 5y median -0.0× FY 2025
Interest Coverage -3.1×
FY 2016 5y median -3.8× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31